Status:
WITHDRAWN
Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Chemotherapy-Induced Peripheral Neuropathy
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This early phase I trial studies how well transcranial direct current stimulation works in reducing pain in cancer patients with chemotherapy induced peripheral neuropathy. Transcranial direct current...
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate the efficacy of transcranial direct current stimulation (tDCS) in reducing chemotherapy induced painful peripheral neuropathy (CIPPN). Ia. Evaluate the change in p...
Eligibility Criteria
Inclusion
- Inclusion:
- Age greater than or equal to 18 years.
- Able to give a Voluntary written consent.
- Cancer patients with chemotherapy induced peripheral neuropathy of at least 3 months duration..
- Pain and/or tingling of at least 4/10
- Exclusion:
- History of seizure
- History of migraine headache
- History of brain cancer and/or brain metastasis
Exclusion
Key Trial Info
Start Date :
October 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 26 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04135326
Start Date
October 10 2019
End Date
October 26 2020
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030